Ettore Dolcetti
IRCCS Neuromed, IS
Pozzilli, Italy
Pozzilli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].
Journal: Brain, behavior, and immunity
Published: August 12, 2026
CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: May 21, 2026
Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.
Journal: Brain, behavior, and immunity
Published: August 04, 2025
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.
Journal: Science translational medicine
Published: May 28, 2025
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 15, 2025
Effect of Anodal Transcranial Direct Current Stimulation on the Intensity of Post-dural Puncture Headache: Results of Two Randomized Sham Controlled Trials.
Journal: Neurology and therapy
Published: January 23, 2025
Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment.
Journal: Frontiers in psychiatry
Published: January 08, 2025
Cladribine tablets in the new multiple sclerosis era.
Journal: Therapeutic advances in neurological disorders
Published: December 05, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: July 08, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
Journal: Frontiers in molecular neuroscience
Published: May 09, 2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis.
Journal: Current neuropharmacology
Published: April 22, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple Sclerosis.
Journal: Current neuropharmacology
Published: April 22, 2024
Last Updated: 09/26/2026